Perrigo Looks To Spin Out Or Sell Off Rx Business, But Will Separating Generics Add Value?

Perrigo previously saw value in keeping its prescription pharmaceuticals in-house, but now says it will sell off or spin out the topical generics to focus on its over-the-counter brands. Questions remain about whether the company's generics portfolio is valuable enough to stand alone or attract a buyer.